NASDAQ$ADUS

Addus HomeCare Corporation · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

Addus HomeCare reported strong Q4 2022 financial results, with revenue growth and increased profitability.

Addus HomeCare Corporation announced a 10.0% increase in net service revenues for Q4 2022, reaching $247.1 million. Net income rose to $14.8 million, or $0.91 per diluted share, and adjusted earnings per diluted share increased to $1.11. The company's strong balance sheet and disciplined financial management support continued investment in the business and strategic acquisitions.

  • Revenues grew by 10.0% to $247.1 million in Q4 2022.
  • Net income reached $14.8 million, with earnings per diluted share at $0.91.
  • Adjusted earnings per diluted share increased to $1.11.
  • Cash flow from operations was $24.3 million for the quarter.

Headline financials

Total Revenue

$247M

Previous: $225M+10.0%
EPS (adj)

$1.11

Previous: $0.97+14.4%
Personal Care organic growth

7.9%

No prior period
Hospice organic growth

-4.9%

Previous: 1.3%-476.9%
Home Health organic growth

8.3%

No prior period
Capital Expenditures

$5.44M

Previous: $1.43M+279.9%
Free Cash Flow

$18.9M

Previous: $23.8M-20.7%
Net Income

$14.8M

Previous: $13.1M+13.0%
Operating Income

$20.8M

Previous: $19.4M+7.5%
Gross Profit

$78.8M

Previous: $72.8M+8.2%
Cash & Equivalents

$80M

Previous: $169M-52.7%
Total Assets

$938M

Previous: $948M-1.0%
Stock-Based Comp

$2.68M

Previous: $2.33M+15.1%

Revenue & EPS history

Addus · Revenue · Quarterly

$247M

Q4 2022+10%vs Q4 2021
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Addus · $247M total across 3 segments · Q4 2022

  • Personal Care
    $183M+4.7%
  • Hospice
    $50.6M+26.0%
  • Home Health
    $13.1M+39.4%

Forward guidance

Addus is focused on investing in its business, including new technology and acquisitions, to support caregivers, enhance recruiting, and expand clinical service capabilities. The company expects a more favorable acquisition environment in 2023 and is well-positioned to meet the growing demand for home-based care.

Tailwinds

  • Strong balance sheet and disciplined financial management
  • Capital to continue investing in the business
  • Focus on acquisition strategy
  • Confident in development team’s ability to capitalize on new acquisition targets
  • Belief in a more favorable acquisition environment in 2023

Headwinds

  • Lingering headwinds related to the pandemic
  • Challenging labor market for health care providers
  • External factors have affected the timing of some opportunities
  • Medicare sequestration
  • Decrease in same store average daily census of 0.9%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

+1.2%

Avg return

Earnings day

+2.3%

Avg return

5 days after

+5.0%

Avg return

30 days after

58%

37 / 64 earnings

Positive

+23.7%

Q4 2019

Best reaction

-19.6%

Q4 2013

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.7%-0.6%-10.6%
Q4 2025-9.1%-12.0%-17.0%
Q3 2025-5.9%-5.0%-4.1%
Q1 2025+4.1%+6.3%+7.5%
Q4 2024-10.4%-12.0%-10.1%
Q3 2024-1.7%+1.0%-2.1%
Q2 2024+3.5%+3.6%+8.5%
Q1 2024+6.5%+11.3%+16.8%
Q4 2023+3.4%+5.3%+16.4%
Q3 2023-3.7%+3.3%+7.0%
Q2 2023+1.2%+3.9%-0.1%
Q1 2023+5.8%+0.3%+10.3%
Q4 2022+3.9%+2.5%-0.4%
Q3 2022+3.1%+3.8%+4.8%
Q2 2022+3.1%+0.6%-3.9%
Q1 2022-2.3%-4.7%-4.2%
Q4 2021+20.5%+20.4%+15.8%
Q3 2021-0.5%+9.1%-8.9%
Q2 2021+9.1%+5.3%+4.0%
Q1 2021-6.6%-8.1%-10.0%
Q4 2020-11.3%-14.2%-11.3%
Q3 2020+11.9%+10.3%+4.6%
Q2 2020+2.7%-4.6%-7.1%
Q1 2020+10.2%+2.7%+22.5%
Q4 2019+23.7%+8.5%+42.1%
Q3 2019-0.9%-0.1%+8.6%
Q2 2019+1.4%+4.4%-0.2%
Q1 2019+3.6%+3.0%+8.8%
Q4 2018-2.8%-7.8%-3.8%
Q3 2018+6.5%+10.8%+16.7%
Q2 2018-4.4%-7.1%-3.4%
Q1 2018+3.1%+1.8%+11.9%
Q4 2017-0.3%+8.6%+38.5%
Q3 2017-1.4%-5.8%-7.8%
Q2 2017-0.3%-1.4%-1.3%
Q1 2017+11.3%+9.4%+2.6%
Q4 2016+1.2%+0.1%-7.5%
Q3 2016+17.4%+28.7%+32.7%
Q2 2016+13.8%+8.6%+27.1%
Q1 2016-1.1%
Q4 2015-16.6%
Q3 2015-12.7%
Q2 2015+4.4%
Q1 2015-3.4%
Q4 2014+3.7%
Q3 2014+7.1%
Q2 2014+1.3%
Q1 2014+1.8%
Q4 2013-19.6%
Q3 2013+4.3%
Q2 2013+9.3%
Q1 2013+0.9%
Q4 2012+13.2%
Q3 2012+10.5%
Q2 2012+1.1%
Q1 2011-0.0%
Q1 2012-7.8%
Q4 2011+6.6%
Q3 2010-1.3%
Q3 2011-1.3%
Q2 2011-17.3%
Q2 2010-17.3%
Q4 2010+0.2%
Q1 2010+2.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro